Shift Pharmaceuticals is developing Antisense Oligonucleotides as drug candidates for a variety of genetic disorders, including Charcot Marie Tooth Syndrome (CMT1A) and Spinal Muscular Atrophy (SMA). Rather than alleviating certain disease side effects, these molecules “SHIFT” the body’s natural protein production back into alignment effectively addressing the core cause of the disease.
We are supported with funding from the NIH, DoD, CMT Research Foundation, and Gwendolyn Strong Foundation.
Company Details
- Employees
- 5
- Address
- Overland Park, Kansas, Us
- Phone
- +1 6268932514
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- New Minas.
- HQ
- Overland Park, Kansas
Shift Pharmaceuticals Questions
Shift Pharmaceuticals's helpline number is +1 6268932514
Shift Pharmaceuticals's website is https://www.shiftpharmaceuticals.com/
Shift Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/shiftpharmaceuticals
Shift Pharmaceuticals has
5 employees.
View email and phone details for 5
employees at Shift Pharmaceuticals.
Shift Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Shift Pharmaceuticals's top competitors are
Flux Tensor Corp.,
Reignite Therapeutics, Inc.,
Rush University Medical Center,
Basin Lake Capital,
Chemeleon,
Elle, Md Biotechnologies,
Max Biopharma, Inc.,
Soilcea,
Saku Biosciences,
Fluid Efficiency.
Shift Pharmaceuticals's categories are Pharmaceutical Manufacturing
